Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for SoftMedX Healthcare's Net Margin % or its related term are showing as below:
HKSE:00648'
s Net Margin % Range Over the Past 10 Years
Min: -1546.5 Med: -151.58 Max: 597.22
Current: 12.39
HKSE:00648's Net Margin % is ranked better than 83.81% of 667
companies
in the Healthcare Providers & Services industry
Industry Median: 2.92
vs HKSE:00648: 12.39
SoftMedX Healthcare (HKSE:00648) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
SoftMedX Healthcare Net Margin % Related Terms
SoftMedX Healthcare Net Margin % Historical Data
* Premium members only.
The historical data trend for SoftMedX Healthcare's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00648 vs HCA, THC, DVA: Net Margin % Comparison
For the Medical Care Facilities subindustry, SoftMedX Healthcare's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SoftMedX Healthcare Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SoftMedX Healthcare's Net Margin % distribution charts can be found below:
* The bar in red indicates where SoftMedX Healthcare's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SoftMedX Healthcare (HKSE:00648) has a Net Margin % of 13.64% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on SoftMedX Healthcare and its competitors. According to the industry distribution chart, SoftMedX Healthcare ranks #108 out of 667 companies in the Healthcare Providers & Services industry, placing it in the top 16.2%.
Is SoftMedX Healthcare's Net Margin % too high?
SoftMedX Healthcare's current Net Margin % is 13.64%. The Healthcare Providers & Services industry median Net Margin % is 2.92. SoftMedX Healthcare's value of 13.64% is 367.1% above this industry median. Based on the distribution chart, SoftMedX Healthcare ranks #108 out of 667 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, SoftMedX Healthcare has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SoftMedX Healthcare's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, SoftMedX Healthcare ranks #108 out of 667 companies for Net Margin %. This places SoftMedX Healthcare in the top 16% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.92. SoftMedX Healthcare's value of 13.64% is 367.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.92, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SoftMedX Healthcare's current Net Margin % of 13.64% is 367.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on SoftMedX Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SoftMedX Healthcare's current Net Margin % is 13.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SoftMedX Healthcare stock overvalued right now?
Based on GuruFocus' analysis, SoftMedX Healthcare (HKSE:00648) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.52, compared to a current price of HK$0.59 — trading 76.6% below its estimated fair value. The current Net Margin % is 13.64% and 367.1% above the Healthcare Providers & Services industry median of 2.92. SoftMedX Healthcare's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For SoftMedX Healthcare (HKSE:00648), the current Net Margin % is 13.64% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SoftMedX Healthcare (HKSE:00648) Overvalued in 2026?
Based on GuruFocus' analysis, SoftMedX Healthcare stock appears to be undervalued.
The current stock price of HK$0.59 is trading 76.6% below its estimated GF Value™ of HK$2.52.
GuruFocus considers SoftMedX Healthcare to be Possible Value Trap.
Key valuation signals for HKSE:00648:
Net Margin %: 13.64%
GF Value™: HK$2.52 vs. price of HK$0.59 (76.6% below fair value)
Industry Position: 367.1% above the Healthcare Providers & Services median (#108 of 667)
No single metric tells the full story. See the HKSE:00648 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SoftMedX Healthcare Ltd is principally engaged in the distribution of medical and healthcare equipment and products. The Group has one reportable operating segment: medical and well-being business, for the Distribution of medical and healthcare equipment and products.
54GF Score
Get the complete analysis for HKSE:00648
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00648 has been successfully added to your 
